Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: PDS/TPL/PTSC-from ASHM

"I was told that his response was something to the effect that TPL is getting about 80% with 20% going to Phoenix."

Well, I too talked to attendees of the AMS, including lengthy discussion with a very heavy hitter. The above had to do with future intent (a policy shift), dedicating greater resources to Alliacense to more aggressively identify and pursue infringers. The "80%" of future revenuse from the MMP are planned to go to Alliacense (not TPL per se). It's called "putting the money where it can do the most good", recognizing a window of opportunity that is closing.

FWIW,

SGE

Share
New Message
Please login to post a reply